Gliaid MV 2.3 Tablet ER
Marketer
Workcell Solutions Private Limited
Salt Composition
Glimepiride (2mg) + Metformin (500mg) + Voglibose (0.3mg)
Overview Gliaid MV 2.3 Tablet ER
Diabetol Duo 2.3 Extended-Release tablets are classified as antidiabetic agents. This dual-action medication manages type 2 diabetes in adults by regulating blood glucose. Diabetol Duo 2.3 ER should be ingested with food, consistently at the same time daily for optimal efficacy. Dosage is determined by your physician and may be adjusted based on blood sugar monitoring. Continued use is crucial, even with controlled blood sugar, as abrupt cessation can lead to elevated glucose levels, increasing the risk of complications such as nephropathy, retinopathy, neuropathy, and limb loss. Remember, this medication complements a comprehensive diabetes management plan including diet, exercise, and weight management as directed by your doctor. Lifestyle choices are integral to diabetes control. Hypoglycemia (low blood sugar) is a prevalent side effect. Learn to identify symptoms like sweating, dizziness, headache, and tremors, and know how to treat them promptly. Maintain regular meals and carry a readily available glucose source, such as sugary snacks or juice. Alcohol consumption should be limited due to its potential to worsen hypoglycemia. Additional potential side effects include altered taste perception, nausea, diarrhea, abdominal discomfort, cephalalgia, edema, blurred vision, bone fractures, and upper respiratory infections. Weight gain may occur in some patients. This medication is contraindicated in individuals with type 1 diabetes, diabetic ketoacidosis, or severe hepatic or renal impairment. Prior heart disease should be disclosed to your physician before commencing treatment. Consult your doctor before use during pregnancy or breastfeeding. Regular blood glucose monitoring is essential, along with potential blood tests to assess blood cell counts and liver function.
Uses of Gliaid MV 2.3 Tablet ER
Managing type 2 diabetes
Major Benefits of Gliaid MV 2.3 Tablet ER:
Administer this medication precisely as directed by your physician, adhering to the prescribed dosage and treatment schedule. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Gliaid MV 2.3 Tablet ER should be consumed on an empty stomach.
Common Side effects of Gliaid MV 2.3 Tablet ER:
- Nausea
- Diarrhea
- Abdominal pain
- Hypoglycemia (low blood glucose level)
- Loss of appetite
How to use Gliaid MV 2.3 Tablet ER:
Consume this medication precisely as prescribed by your physician, adhering to the recommended dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Administer Gliaid MV 2.3 Tablet ER on an empty stomach.
How Gliaid MV 2.3 Tablet ER works:
Gliaid MV 2.3 Extended-Release tablets contain a triple-action formulation for diabetes management.
SAFETY ADVICE
AlcoholUNSAFE
Avoid alcohol consumption while taking Gliaid MV 2.3 Tablet ER.
PregnancyCONSULT YOUR DOCTOR
The use of Gliaid MV 2.3 Extended-Release Tablets during pregnancy might pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the potential advantages against any possible dangers prior to prescribing this medication. Patient consultation with their doctor is recommended.
Breast feedingCONSULT YOUR DOCTOR
Extended-release Gliaid MV 2.3 tablets are likely not safe for use while breastfeeding. Available human data indicate potential transfer of the medication into breast milk, posing a risk to the infant.
DrivingCAUTION
Driving may be impaired by excessively low or high blood sugar levels. Refrain from driving if you experience these conditions.
KidneyUNSAFE
Patients with kidney disease should likely avoid Gliaid MV 2.3 Tablet ER due to potential safety concerns. Medical advice is recommended. This medication is particularly unsuitable for individuals with severe kidney impairment.
LiverCAUTION
Patients with liver impairment should use Gliaid MV 2.3 Tablet ER cautiously, potentially requiring dose modification. Consult a physician. A reduced initial dose is typically prescribed for individuals with mild to moderate hepatic dysfunction; the medication is contraindicated in those with severe liver disease.
What if you forget to take Gliaid MV 2.3 Tablet ER :
Should you forget a Gliaid MV 2.3 Tablet ER dose, take it immediately. However, near the time for your next dose, omit the missed one and resume your usual dosing pattern. Never take a double dose.
Facts to Know About Gliaid MV 2.3 Tablet ER
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Diabetes Treatment |



